The Food and Drug administration has approved a new COVID-19 vaccine made by Moderna but with limits on who can use it.

They are getting a major change. Only people aged 65 and up, along with certain groups, will be eligible to receive booster shots. FDA officials are asking for more data around the vaccine’s ...

In its Friday approval letter, the FDA didn’t explain the restrictions although they reflect skepticism about ...

The vaccine advisory committee for the Food and Drug Administration met Thursday to discuss potential changes to the formula ...

Moderna announced this weekend that the Food and Drug Administration approved its lower-dose Covid-19 vaccine for adults 65 ...

Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...

That's the same limit the FDA set in licensing another COVID-19 vaccine option from competitor Novavax. Those restrictions are a departure from how the U.S. has handled COVID-19 vaccines until now ...

Healthy younger adults and children will no longer be automatically approved for annual COVID-19 vaccines under a new policy ...

The Trump administration’s shift to narrow approval for coronavirus vaccines to only those who are at high risk for severe disease has raised concerns among Americans who came to rely on annual ...

Earlier this month, the FDA approved Novavax's COVID-19 vaccine with age restrictions after a six-week delay. The agency approved the vaccine only for people 65 and older and those 12 and older ...

That’s the same limit that the FDA set in licensing another COVID-19 vaccine option from competitor Novavax. Those restrictions are a departure from how the U.S. has handled COVID-19 vaccines ...